WO2023037264 - CONTRACEPTIVE REGIMEN INCLUDING REDUCED LEVEL OF ESTROGEN
National phase entry:
Publication Number
WO/2023/037264
Publication Date
16.03.2023
International Application No.
PCT/IB2022/058420
International Filing Date
07.09.2022
Title **
[English]
CONTRACEPTIVE REGIMEN INCLUDING REDUCED LEVEL OF ESTROGEN
[French]
RÉGIME CONTRACEPTIF COMPRENANT UN NIVEAU RÉDUIT D'OESTROGÈNE
Applicants **
MILLICENT PHARMA LIMITED
Block 4 Floor 2, Quayside Business Park
Mill Street
County Louth
Dundalk, A91 KA9R, IE
Inventors
BOISSONNEAULT, Roger M.
c/o Millicent Pharma Limited
Block 4 Floor 2, Quayside Business Park
Mill Street, County Louth
Dundalk, A91 KA9R, IE
LOUGHLIN, Ryan
c/o Millicent Pharma Limited
Block 4 Floor 2, Quayside Business Park
Mill Street, County Louth
Dundalk, A91 KA9R, IE
Priority Data
63/241,178
07.09.2021
US
17/483,199
23.09.2021
US
Application details
| Total Number of Claims/PCT | * |
| Number of Independent Claims | * |
| Number of Priorities | * |
| Number of Multi-Dependent Claims | * |
| Number of Drawings | * |
| Pages for Publication | * |
| Number of Pages with Drawings | * |
| Pages of Specification | * |
| * | |
| * | |
International Searching Authority |
EPO
* |
| Applicant's Legal Status |
Legal Entity
* |
| * | |
| * | |
| * | |
| * | |
| Entry into National Phase under |
Chapter I
* |
| Translation |
|
Recalculate
* The data is based on automatic recognition. Please verify and amend if necessary.
** IP-Coster compiles data from publicly available sources. If this data includes your personal information, you can contact us to request its removal.
Quotation for National Phase entry
| Country | Stages | Total | |
|---|---|---|---|
| China | Filing | 1683 | |
| EPO | Filing, Examination | 10557 | |
| Japan | Filing | 590 | |
| South Korea | Filing | 607 | |
| USA | Filing, Examination | 8310 |
Total: 21747 USD
The term for entry into the National Phase has expired. This quotation is for informational purposes only
Abstract[English]
A contraceptive regimen that provides for a reduced level of estrogen. The contraceptive regimen can be used for the treatment of symptoms associated with endometriosis or fibroids.[French]
L'invention concerne un régime contraceptif qui permet une réduction du niveau d'oestrogène. Le régime contraceptif peut être utilisé afin de traiter des symptômes associés à l'endométriose ou à des fibromes.